489 related articles for article (PubMed ID: 18417182)
1. Gene expression changes induced by ochratoxin A in renal and hepatic tissues of male F344 rat after oral repeated administration.
Arbillaga L; Vettorazzi A; Gil AG; van Delft JH; García-Jalón JA; López de Cerain A
Toxicol Appl Pharmacol; 2008 Jul; 230(2):197-207. PubMed ID: 18417182
[TBL] [Abstract][Full Text] [Related]
2. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
3. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat.
Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Mansourian R; Holzwarth J; Grigorov M; Delatour T; Mantle P; Cavin C; Schilter B
Toxicol Sci; 2006 Jan; 89(1):120-34. PubMed ID: 16251485
[TBL] [Abstract][Full Text] [Related]
4. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats.
Mally A; Völkel W; Amberg A; Kurz M; Wanek P; Eder E; Hard G; Dekant W
Chem Res Toxicol; 2005 Aug; 18(8):1242-52. PubMed ID: 16097797
[TBL] [Abstract][Full Text] [Related]
5. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/n rats.
Rached E; Hard GC; Blumbach K; Weber K; Draheim R; Lutz WK; Ozden S; Steger U; Dekant W; Mally A
Toxicol Sci; 2007 Jun; 97(2):288-98. PubMed ID: 17344223
[TBL] [Abstract][Full Text] [Related]
6. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.
Adler M; Müller K; Rached E; Dekant W; Mally A
Carcinogenesis; 2009 Apr; 30(4):711-9. PubMed ID: 19237604
[TBL] [Abstract][Full Text] [Related]
7. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats.
Mally A; Pepe G; Ravoori S; Fiore M; Gupta RC; Dekant W; Mosesso P
Chem Res Toxicol; 2005 Aug; 18(8):1253-61. PubMed ID: 16097798
[TBL] [Abstract][Full Text] [Related]
8. Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity.
Cavin C; Delatour T; Marin-Kuan M; Holzhäuser D; Higgins L; Bezençon C; Guignard G; Junod S; Richoz-Payot J; Gremaud E; Hayes JD; Nestler S; Mantle P; Schilter B
Toxicol Sci; 2007 Mar; 96(1):30-9. PubMed ID: 17110534
[TBL] [Abstract][Full Text] [Related]
9. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats.
Kamp HG; Eisenbrand G; Janzowski C; Kiossev J; Latendresse JR; Schlatter J; Turesky RJ
Mol Nutr Food Res; 2005 Dec; 49(12):1160-7. PubMed ID: 16302199
[TBL] [Abstract][Full Text] [Related]
10. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays.
Luhe A; Hildebrand H; Bach U; Dingermann T; Ahr HJ
Toxicol Sci; 2003 Jun; 73(2):315-28. PubMed ID: 12700408
[TBL] [Abstract][Full Text] [Related]
11. Molecular biomarkers of oxidative stress associated with bromate carcinogenicity.
Delker D; Hatch G; Allen J; Crissman B; George M; Geter D; Kilburn S; Moore T; Nelson G; Roop B; Slade R; Swank A; Ward W; DeAngelo A
Toxicology; 2006 Apr; 221(2-3):158-65. PubMed ID: 16442688
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro.
Rached E; Hoffmann D; Blumbach K; Weber K; Dekant W; Mally A
Toxicol Sci; 2008 Jun; 103(2):371-81. PubMed ID: 18308701
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation and nephrotoxicity of ochratoxin B in rats.
Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W
Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343
[TBL] [Abstract][Full Text] [Related]
14. Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity.
Arbillaga L; Azqueta A; Ezpeleta O; López de Cerain A
Mutagenesis; 2007 Jan; 22(1):35-42. PubMed ID: 17130176
[TBL] [Abstract][Full Text] [Related]
15. Protective role of melatonin and coenzyme Q10 in ochratoxin A toxicity in rat liver and kidney.
Sutken E; Aral E; Ozdemir F; Uslu S; Alatas O; Colak O
Int J Toxicol; 2007; 26(1):81-7. PubMed ID: 17365150
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and oxidative stress induced by ochratoxin A in rat kidney.
Petrik J; Zanić-Grubisić T; Barisić K; Pepeljnjak S; Radić B; Ferencić Z; Cepelak I
Arch Toxicol; 2003 Dec; 77(12):685-93. PubMed ID: 13680094
[TBL] [Abstract][Full Text] [Related]
17. Immunotoxic effects of Ochratoxin A in Wistar rats after oral administration.
Alvarez L; Gil AG; Ezpeleta O; García-Jalón JA; López de Cerain A
Food Chem Toxicol; 2004 May; 42(5):825-34. PubMed ID: 15046829
[TBL] [Abstract][Full Text] [Related]
18. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
[TBL] [Abstract][Full Text] [Related]
19. Effect of fenofibrate on oxidative DNA damage and on gene expression related to cell proliferation and apoptosis in rats.
Nishimura J; Dewa Y; Muguruma M; Kuroiwa Y; Yasuno H; Shima T; Jin M; Takahashi M; Umemura T; Mitsumori K
Toxicol Sci; 2007 May; 97(1):44-54. PubMed ID: 17264098
[TBL] [Abstract][Full Text] [Related]
20. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats.
Davidson ME; Kerepesi LA; Soto A; Chan VT
Arch Toxicol; 2009 Aug; 83(8):747-62. PubMed ID: 19212759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
